OS Therapies Incorporated (NYSE: OSTX) — Healthcare · Share Price, Chart & Market Data
About: OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.77 (+22.07%)
OSTXOS Therapies Incorporated
Loading watchlist status…
Trade OSTX now
OS Therapies Incorporated share price
OSTX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:11 am GMT+0
OSTX price performance
28.261%
5D
25.532%
1M
32.09%
YTD
-2.747%
1Y
OSTX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:11 am GMT+0
OSTX details
OSTX Market Signals